 MTBC is pleased to reaffirm our 2020 full-year revenue guidance of 100 102 million and adjusted EBITDA guidance of 12 13 million, despite the uncertainty in the U.S. economy from the COVID-19 pandemic and the related significant decline in non-emergency doctor visits, said Bill Korn, MTBC Chief Financial Officer. MTBC helps clients increase financial and operational performance, streamline clinical workflows and make better business and clinical decisions, allowing them to improve patient care while reducing administrative burdens and operating costs. 